NCT03232645View on ClinicalTrials.gov

Electrical Coupling Information From The Rhythmia HDx System And DirectSense Technology In Subjects With Paroxysmal Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

January 8, 2018

Primary Completion Date

June 23, 2020

Study Completion Date

August 5, 2020

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DEVICE

Ablation procedure

Cathater ablation of pulmonary veins with the Rhythmia HDx mapping system, IntellaMap Orion mapping catheter and IntellaNav Mifi OI ablation catheter

Trial Locations (6)

Unknown

CHU de Bordeaux, Bordeaux

Universitäres Herzzentrum Hamburg, Hamburg

Stadtisches Klinikum Karlsruhe, Karlsruhe

Clinica Universitaria de Navarra, Pamplona

Freeman Hospital, Newcastle

SO16 6YD

Southampton General Hospital, Southampton

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT03232645 - Electrical Coupling Information From The Rhythmia HDx System And DirectSense Technology In Subjects With Paroxysmal Atrial Fibrillation | Biotech Hunter | Biotech Hunter